ANDA 87785, held by Watson Labs. Quinidine Gluconate.
As of Nov 15, 2026, ANDA 87785 (Quinidine Gluconate), held by Watson Labs, was first approved by FDA on Jan 24, 1983, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 24, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Quinidine Gluconate324MG ยท tablet, extended release;oral | Quinidine Gluconate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
